RFG
IRWD icon

RFP Financial Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

RFP Financial Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-47
Closed -$538 – 900
2023
Q4 		$538 Hold
47
– – ﹤0.01% 831
2023
Q3 		$453 Hold
47
– – ﹤0.01% 856
2023
Q2 		$500 Hold
47
– – ﹤0.01% 890
2023
Q1 		$494 Hold
47
– – ﹤0.01% 705
2022
Q4 		$582 Buy
+47
New +$533 ﹤0.01% 851

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

RFP Financial Group's IRWD Position: Q1 2024 in Review

RFP Financial Group sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 47 shares — an estimated $538 sold.

RFP Financial Group first reported a position in IRWD in Q4 2022 and held it in 5 quarters. The position peaked at $582 in Q4 2022. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

  • RFP Financial Group reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • RFP Financial Group sold 47 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $538.
  • RFP Financial Group first reported a position in Ironwood Pharmaceuticals in Q4 2022 and held it in 5 quarters.
  • RFP Financial Group's Ironwood Pharmaceuticals position peaked at $582 in Q4 2022.
  • 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on RFP Financial Group's 13F filing for Q1 2024, filed 9 May 2024.